Health Care & Life Sciences » Pharmaceuticals | Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
Market Cap
$57.01 M
Shares Outstanding
17.38 M
Public Float
12.3 M


Hi-Tech Park 2/4
Jerusalem JM 91390
Employees -
Updated 07/08/2019
Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in Jerusalem, Israel.


View All

Nadav Kidron
President, Chief Executive Officer & Director
Miriam Kidron
Director, Chief Medical & Scientific Officer